摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3'-carboethoxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-[1,1'-biphenyl]-6-acetic acid | 163118-15-8

中文名称
——
中文别名
——
英文名称
3'-carboethoxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-[1,1'-biphenyl]-6-acetic acid
英文别名
2-[2-(3-Ethoxycarbonylphenyl)-3-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)methoxy]phenyl]acetic acid
3'-carboethoxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-[1,1'-biphenyl]-6-acetic acid化学式
CAS
163118-15-8
化学式
C32H36O5
mdl
——
分子量
500.635
InChiKey
JJIJGOTXPVGSKD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.8
  • 重原子数:
    37
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    72.8
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    3'-carboethoxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-[1,1'-biphenyl]-6-acetic acidsodium hydroxide 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 2.0h, 以85%的产率得到3'-carboxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-[1,1'-biphenyl]-6-acetic acid
    参考文献:
    名称:
    Biaryl diacid inhibitors of human s-PLA 2 with anti-inflammatory activity
    摘要:
    Twenty-four hydrophobic dicarboxylic acids are described which were evaluated as inhibitors of 14 kDa human platelet phospholipase A(2) (HP-PLA(2)). In general, biarylacetic acid derivatives were found to be more active than biaryl acids or biaryl-propanoic acids. More potent inhibitors were obtained when hydrophobic groups were attached to the biaryl acid nucleus using an olefin linkage as compared to an ether linkage. Compounds with larger hydrophobic groups were usually more potent inhibitors of HP-PLA(2). Five of the compounds disclosed in this report (2, 4, 28, 36b and 36i) were found to possess significant anti-inflammatory activity in a phorbol ester induced mouse ear edema model of chronic inflammation. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00047-x
  • 作为产物:
    描述:
    6'-((E)-2-Methoxy-vinyl)-2'-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-ylmethoxy)-biphenyl-3-carboxylic acid ethyl ester 在 盐酸sodium chlorite氨基磺酸 作用下, 以 四氢呋喃 为溶剂, 反应 24.25h, 生成 3'-carboethoxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-[1,1'-biphenyl]-6-acetic acid
    参考文献:
    名称:
    Biaryl diacid inhibitors of human s-PLA 2 with anti-inflammatory activity
    摘要:
    Twenty-four hydrophobic dicarboxylic acids are described which were evaluated as inhibitors of 14 kDa human platelet phospholipase A(2) (HP-PLA(2)). In general, biarylacetic acid derivatives were found to be more active than biaryl acids or biaryl-propanoic acids. More potent inhibitors were obtained when hydrophobic groups were attached to the biaryl acid nucleus using an olefin linkage as compared to an ether linkage. Compounds with larger hydrophobic groups were usually more potent inhibitors of HP-PLA(2). Five of the compounds disclosed in this report (2, 4, 28, 36b and 36i) were found to possess significant anti-inflammatory activity in a phorbol ester induced mouse ear edema model of chronic inflammation. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00047-x
点击查看最新优质反应信息

文献信息

  • Biaryl phospholipase A2 inhibitors
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:EP0664282A1
    公开(公告)日:1995-07-26
    Biaryl compounds, effective phospholipase A₂ (PLA₂) inhibitors of Formulas I and II: wherein: Y= COOH, CH₂CO₂H, H, F, Cl, Br, I, COOR', CH₂CO₂R', CONH₂, COR'', CHO, CH₂OH, CH₂OR'', OH, OR'', CF₃, C₁₋₆ alkyl, C₁₋₆ alkenyl, C₁₋₆ haloalkyl, NO₂, P(O) (OH)₂, SO₂H, or SO₃H; Z= H, F, Cl, Br, I, CONH₂, COR'', CHO, CH₂OH, CH₂OR'', OH, OR'', CF₃, C₁₋₆ alkyl, C₁₋₆ alkenyl, C₁₋₆ haloalkyl, NO₂, P(O)(OH)₂, SO₂H, or SO₃H; X= (CH₂)n, n = 0, 1, or 2; or a cis or trans CH=CH; R= substituted or unsubstituted alkyl, aryl, arylalkyl, alkyloxy, arylalkyloxy, alkenyl, or arylalkenyl groups with the proviso that R must have 8 or more carbons; R'= H, C₁₋₆ alkyl, C(R¹)₂OC(O)R², CH₂CH₂NR³R⁴, CH₂CH₂CH₂NR³R⁴, or other groups yielding physiologically hydrolyzable esters; R''= C₁₋₆ alkyl; R¹= H, CH₃, C₂H₅, CH₂CH₂CH₃; R₂= C₆₋₁₂ aryl, C₁₋₇ linear, branched or cyclic alkyl, or C₁₋₇ linear branched or cyclic alkoxy; R³= R⁴, or, it may be linked with R⁴, to form a C₃-C₆ cycloalkyl or a -CH₂CH₂OCH₂CH₂- group; and R⁴= C₁₋₃ alkyl; or salts thereof.
    式 I 和 II 的有效磷脂酶 A₂(PLA₂)抑制剂--联苯化合物: 其中 Y= COOH、CH₂CO₂H、H、F、Cl、Br、I、COOR'、CH₂CO₂R'、CONH₂、COR''、CHO、CH₂OH、CH₂OR''、OH、OR''、CF₃、C₁₋₆ 烷基、C₁₋₆ 烯基、C₁₋₆ 卤代烷基、NO₂、P(O) (OH)₂、SO₂H 或 SO₃H; Z= H、F、Cl、Br、I、CONH₂、COR''、CHO、CH₂OH、CH₂OR''、OH、OR''、CF₃、C₁₋₆ 烷基、C₁₋₆ 烯基、C₁₋₆ 卤代烷基、NO₂、P(O)(OH)₂、SO₂H 或 SO₃H; X= (CH₂)n,n = 0、1 或 2;或顺式或反式 CH=CH; R= 取代或未取代的烷基、芳基、芳烷基、烷氧基、芳烷氧基、烯基或芳烯基,但 R 必须具有 8 个或 8 个以上碳原子; R'=H、C₁₋₆烷基、C(R¹)₂OC(O)R²、CH₂CH₂NR³R⁴、CH₂CH₂CH₂NR³R⁴或其他可产生生理性解酯的基团; R''= C₁₋₆ 烷基; R¹= h、ch₃、c₂h₅、ch₂ch₂ch₃; R₂= C₆₋₁₂ 芳基,C₁₋₇ 直链、支链或环状烷基,或 C₁₋₇ 直链、支链或环状烷氧基; R³= R⁴,或可与 R⁴ 连接,形成 C₃-C₆ 环烷基或 -CH₂CH₂OCH₂CH₂- 基团;以及 R⁴= C₁₋₃ 烷基;或其盐。
  • US5391817A
    申请人:——
    公开号:US5391817A
    公开(公告)日:1995-02-21
查看更多